A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...

Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

Purple Biotech (PPBT) is advancing into a Phase 2 study with NT219 in patients with recurrent/metastatic squamous cell carcinoma of the head ...

NT219, a novel agent designed to overcome tumor resistance to drug therapy, will be evaluated in combination with the standard-of-care head and ...

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

Syensqo & Bota Bio partner to develop pioneering biomimetic ingredients for hair and scalp care: Brussels Tuesday, February 11, 2025, 17:00 Hrs [IST] Syensqo, a science company de ...

Several biotechnology companies are embracing these ... AbbVie (NYSE: ABBV) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, including a strong ...

The selection of projects comes from product design engineering, bio design, industrial design, and master of design courses ...

Entrada Therapeutics' innovative Endosomal Escape Vehicle platform, poised to revolutionize drug delivery. Click here to read ...

It has received multiple international approvals, including recognition from the Ministry of Health in Malaysia, a Non-Pesticide classification by the Malaysian Pesticide Board and is also approved by ...

AlgoTherapeutix (AlgoTx), a clinical stage biotechnology company developing a first-in-class therapeutic for peripheral ...